181 related articles for article (PubMed ID: 24789216)
1. The CCAAT/enhancer-binding protein beta-2 isoform (CEBPβ-2) upregulates galectin-7 expression in human breast cancer cells.
Campion CG; Labrie M; Grosset AA; St-Pierre Y
PLoS One; 2014; 9(5):e95087. PubMed ID: 24789216
[TBL] [Abstract][Full Text] [Related]
2. CCAAT/enhancer binding protein β (C/EBPβ) isoforms as transcriptional regulators of the pro-invasive CDH3/P-cadherin gene in human breast cancer cells.
Albergaria A; Resende C; Nobre AR; Ribeiro AS; Sousa B; Machado JC; Seruca R; Paredes J; Schmitt F
PLoS One; 2013; 8(2):e55749. PubMed ID: 23405208
[TBL] [Abstract][Full Text] [Related]
3. Malignant breast epithelial cells stimulate aromatase expression via promoter II in human adipose fibroblasts: an epithelial-stromal interaction in breast tumors mediated by CCAAT/enhancer binding protein beta.
Zhou J; Gurates B; Yang S; Sebastian S; Bulun SE
Cancer Res; 2001 Mar; 61(5):2328-34. PubMed ID: 11280806
[TBL] [Abstract][Full Text] [Related]
4. CCAAT/enhancer-binding protein beta (nuclear factor for interleukin 6) transactivates the human MDR1 gene by interaction with an inverted CCAAT box in human cancer cells.
Chen KG; Sale S; Tan T; Ermoian RP; Sikic BI
Mol Pharmacol; 2004 Apr; 65(4):906-16. PubMed ID: 15044620
[TBL] [Abstract][Full Text] [Related]
5. Expression of galectin-7 is induced in breast cancer cells by mutant p53.
Campion CG; Labrie M; Lavoie G; St-Pierre Y
PLoS One; 2013; 8(8):e72468. PubMed ID: 23967302
[TBL] [Abstract][Full Text] [Related]
6. Expression of the CCAAT/enhancer-binding proteins C/EBPalpha, C/EBPbeta and C/EBPdelta in breast cancer: correlations with clinicopathologic parameters and cell-cycle regulatory proteins.
Milde-Langosch K; Löning T; Bamberger AM
Breast Cancer Res Treat; 2003 May; 79(2):175-85. PubMed ID: 12825852
[TBL] [Abstract][Full Text] [Related]
7. CCAAT/enhancer binding protein β negatively regulates progesterone receptor expression in human glioblastoma cells.
Hansberg-Pastor V; González-Arenas A; Camacho-Arroyo I
Mol Cell Endocrinol; 2017 Jan; 439():317-327. PubMed ID: 27663075
[TBL] [Abstract][Full Text] [Related]
8. Regulation of aromatase P450 expression in endometriotic and endometrial stromal cells by CCAAT/enhancer binding proteins (C/EBPs): decreased C/EBPbeta in endometriosis is associated with overexpression of aromatase.
Yang S; Fang Z; Suzuki T; Sasano H; Zhou J; Gurates B; Tamura M; Ferrer K; Bulun S
J Clin Endocrinol Metab; 2002 May; 87(5):2336-45. PubMed ID: 11994385
[TBL] [Abstract][Full Text] [Related]
9. CCAAT/enhancer binding protein beta (C/EBPbeta)-2 transforms normal mammary epithelial cells and induces epithelial to mesenchymal transition in culture.
Bundy LM; Sealy L
Oncogene; 2003 Feb; 22(6):869-83. PubMed ID: 12584567
[TBL] [Abstract][Full Text] [Related]
10. Stat3 and CCAAT/enhancer binding protein beta (C/EBP-beta) regulate Jab1/CSN5 expression in mammary carcinoma cells.
Shackleford TJ; Zhang Q; Tian L; Vu TT; Korapati AL; Baumgartner AM; Le XF; Liao WS; Claret FX
Breast Cancer Res; 2011 Jun; 13(3):R65. PubMed ID: 21689417
[TBL] [Abstract][Full Text] [Related]
11. CCAAT/enhancer binding proteins alpha and beta regulate the tumor necrosis factor receptor 1 gene promoter.
Bristol JA; Morrison TE; Kenney SC
Mol Immunol; 2009 Aug; 46(13):2706-13. PubMed ID: 19523687
[TBL] [Abstract][Full Text] [Related]
12. Regulation of Id2 expression by CCAAT/enhancer binding protein beta.
Karaya K; Mori S; Kimoto H; Shima Y; Tsuji Y; Kurooka H; Akira S; Yokota Y
Nucleic Acids Res; 2005; 33(6):1924-34. PubMed ID: 15809228
[TBL] [Abstract][Full Text] [Related]
13. Complex regulation of the fibroblast growth factor-binding protein in MDA- MB-468 breast cancer cells by CCAAT/enhancer-binding protein beta.
Kagan BL; Henke RT; Cabal-Manzano R; Stoica GE; Nguyen Q; Wellstein A; Riegel AT
Cancer Res; 2003 Apr; 63(7):1696-705. PubMed ID: 12670924
[TBL] [Abstract][Full Text] [Related]
14. Glucocorticoid regulation of the promoter of 11beta-hydroxysteroid dehydrogenase type 1 is indirect and requires CCAAT/enhancer-binding protein-beta.
Sai S; Esteves CL; Kelly V; Michailidou Z; Anderson K; Coll AP; Nakagawa Y; Ohzeki T; Seckl JR; Chapman KE
Mol Endocrinol; 2008 Sep; 22(9):2049-60. PubMed ID: 18617597
[TBL] [Abstract][Full Text] [Related]
15. Expression and function of CCAAT/enhancer binding proteinbeta (C/EBPbeta) LAP and LIP isoforms in mouse mammary gland, tumors and cultured mammary epithelial cells.
Dearth LR; Hutt J; Sattler A; Gigliotti A; DeWille J
J Cell Biochem; 2001; 82(3):357-70. PubMed ID: 11500913
[TBL] [Abstract][Full Text] [Related]
16. Functional association of PR and CCAAT/enhancer-binding protein beta isoforms: promoter-dependent cooperation between PR-B and liver-enriched inhibitory protein, or liver-enriched activatory protein and PR-A in human endometrial stromal cells.
Christian M; Pohnke Y; Kempf R; Gellersen B; Brosens JJ
Mol Endocrinol; 2002 Jan; 16(1):141-54. PubMed ID: 11773445
[TBL] [Abstract][Full Text] [Related]
17. CCAAT/Enhancer binding protein β controls androgen-deprivation-induced senescence in prostate cancer cells.
Barakat DJ; Zhang J; Barberi T; Denmeade SR; Friedman AD; Paz-Priel I
Oncogene; 2015 Nov; 34(48):5912-22. PubMed ID: 25772238
[TBL] [Abstract][Full Text] [Related]
18. MiR-155-mediated loss of C/EBPβ shifts the TGF-β response from growth inhibition to epithelial-mesenchymal transition, invasion and metastasis in breast cancer.
Johansson J; Berg T; Kurzejamska E; Pang MF; Tabor V; Jansson M; Roswall P; Pietras K; Sund M; Religa P; Fuxe J
Oncogene; 2013 Dec; 32(50):5614-24. PubMed ID: 23955085
[TBL] [Abstract][Full Text] [Related]
19. Selective activation of trophoblast-specific PLAC1 in breast cancer by CCAAT/enhancer-binding protein beta (C/EBPbeta) isoform 2.
Koslowski M; Türeci O; Biesterfeld S; Seitz G; Huber C; Sahin U
J Biol Chem; 2009 Oct; 284(42):28607-15. PubMed ID: 19652226
[TBL] [Abstract][Full Text] [Related]
20. CCAAT/enhancer binding protein β regulates expression of Indian hedgehog during chondrocytes differentiation.
Ushijima T; Okazaki K; Tsushima H; Ishihara K; Doi T; Iwamoto Y
PLoS One; 2014; 9(8):e104547. PubMed ID: 25105964
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]